Regulus Therapeutics Inc (RGLS)
2.29
+0.07
(+3.15%)
USD |
NASDAQ |
Apr 25, 16:00
2.29
0.00 (0.00%)
After-Hours: 20:00
Regulus Therapeutics Price: 2.29 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 24, 2024 | 2.29 | 2.29 | 2.22 | 2.22 | 91764.00 |
Apr 23, 2024 | 2.17 | 2.34 | 2.13 | 2.26 | 101587.0 |
Apr 22, 2024 | 2.09 | 2.26 | 2.09 | 2.20 | 127753.0 |
Apr 19, 2024 | 2.23 | 2.31 | 2.09 | 2.13 | 222754.0 |
Apr 18, 2024 | 2.35 | 2.375 | 2.18 | 2.22 | 202895.0 |
Apr 17, 2024 | 2.44 | 2.60 | 2.33 | 2.34 | 295342.0 |
Apr 16, 2024 | 2.70 | 2.78 | 2.53 | 2.56 | 455858.0 |
Apr 15, 2024 | 2.82 | 2.83 | 2.66 | 2.78 | 315039.0 |
Apr 12, 2024 | 2.86 | 2.88 | 2.70 | 2.80 | 343860.0 |
Apr 11, 2024 | 2.63 | 2.86 | 2.62 | 2.78 | 375313.0 |
Apr 10, 2024 | 2.68 | 2.68 | 2.56 | 2.62 | 192166.0 |
Apr 09, 2024 | 2.65 | 2.77 | 2.614 | 2.70 | 220878.0 |
Apr 08, 2024 | 2.59 | 2.76 | 2.510 | 2.67 | 348276.0 |
Apr 05, 2024 | 2.52 | 2.667 | 2.45 | 2.54 | 355953.0 |
Apr 04, 2024 | 2.68 | 2.73 | 2.51 | 2.52 | 266251.0 |
Apr 03, 2024 | 2.79 | 2.79 | 2.60 | 2.61 | 249347.0 |
Apr 02, 2024 | 2.78 | 2.81 | 2.52 | 2.72 | 826612.0 |
Apr 01, 2024 | 2.90 | 2.91 | 2.59 | 2.80 | 912879.0 |
Mar 28, 2024 | 2.81 | 2.93 | 2.80 | 2.88 | 808984.0 |
Mar 27, 2024 | 2.88 | 3.000 | 2.73 | 2.88 | 887017.0 |
Mar 26, 2024 | 2.84 | 3.00 | 2.67 | 2.845 | 832881.0 |
Mar 25, 2024 | 2.70 | 2.99 | 2.67 | 2.82 | 1.084M |
Mar 22, 2024 | 2.80 | 2.84 | 2.56 | 2.685 | 697943.0 |
Mar 21, 2024 | 2.59 | 2.82 | 2.50 | 2.78 | 1.472M |
Mar 20, 2024 | 2.29 | 2.52 | 2.20 | 2.50 | 727426.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.7929
Minimum
Mar 27 2023
19.60
Maximum
Mar 12 2021
5.330
Average
4.599
Median
Sep 04 2020
Price Benchmarks
ACADIA Pharmaceuticals Inc | 16.33 |
ADMA Biologics Inc | 6.445 |
FibroGen Inc | 1.015 |
Protara Therapeutics Inc | 2.99 |
Amylyx Pharmaceuticals Inc | 1.775 |
Price Related Metrics
Price to Book Value | 7.078 |
Earnings Yield | -69.00% |
Market Cap | 149.92M |